MAPT and Alzheimer disease: The senescence-accelerated mouse prone 8 (SAMP8) model, which exhibits early-onset learning and memory deficits alongside key pathological hallmarks of AD—such as elevated oxidative stress, tau hyperphosphorylation, and amyloid plaque deposition—was utilized to evaluate the neuroprotective effects of nobiletin.